Back
Evolent Health Quote, Financials, Valuation and Earnings
Sponsored
EVH
Sponsored
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!
Sell
47
EVH
Evolent Health
Last Price:
27.42
Seasonality Move:
28.04%
7 Day Trial
ALL ACCESS PASS
$
7
America's Final Republican President
Click here to see his 2024 election prediction.Evolent Health Price Quote
$27.42
+0.18 (+0.66%)
(Updated: May 7, 2024 at 2:45 PM ET)
Evolent Health Key Stats
Sell
47
Evolent Health (EVH)
is a Sell
Day range:
$26.99 - $27.42
52-week range:
$23.33 - $35.83
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.54
P/B ratio:
2.91%
Volume:
1.1M
Avg. volume:
791.4K
1-year change:
-19.91%
Market cap:
$3.1B
Revenue:
$2B
EPS:
$-1.27
How Much Does Evolent Health Make?
-
How Much Are Evolent Health's Sales Annually?
EVH Revenues are $2B -
How Much Profit Does Evolent Health's Make A Year?
EVH net income is -$113M
Is Evolent Health Growing As A Company?
-
What Is Evolent Health's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.45% -
What Is Evolent Health's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Evolent Health Stock Price Performance
-
Did Evolent Health Stock Go Up Last Month?
Evolent Health share price went down by -10.28% last month -
Did EVH's Share Price Rise Over The Last Year?
EVH share price fell by -19.91% over the past 1 year
What Is Evolent Health 52-Week High & Low?
-
What Is Evolent Health’s 52-Week High Share Price?
Evolent Health has traded as high as $35.83 over the past 52 weeks -
What Is Evolent Health’s 52-Week Low Share Price?
Evolent Health has traded as low as $23.33 over the past 52 weeks
Evolent Health Price To Free Cash Flow
-
Is Evolent Health Stock Overvalued?
Evolent Health is trading at a price to free cash flow ratio of 26.62 -
Is Evolent Health Stock Undervalued?
Evolent Health EV to Free Cash Flow ratio is 30.80 -
What Is Evolent Health’s Price Earnings Growth Ratio?
EVH PEG ratio is -0.04 -
Is Evolent Health Trading At A Premium To Earnings?
Evolent Health EV to EBIT ratio is 0.00
Is It Risky To Buy Evolent Health?
-
How Much Debt Does Evolent Health Have?
Total long term debt quarterly is $597M -
How Much Cash Does Evolent Health Have?
Cash and short term investments quarterly total is $192.8M -
What Is Evolent Health’s Book Value Per Share?
Book value per share is 9.38
Is Evolent Health Cash Flow Positive?
-
What Is EVH Cash Flow From Operations?
Cash flow from operations (TTM) is $142.6M -
What Is Evolent Health’s Cash Flow From Financing?
Cash flow from financing (TTM) is $281.3M -
What Is Evolent Health’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$415.5M
Evolent Health Return On Invested Capital
-
Is Management Doing A Good Job?
EVH return on invested capital is -6.82% -
What Is Evolent Health Return On Assets?
ROA measures how assets are converting to revenues and is -4.56% -
What Is EVH Return On Equity?
ROE is a measure of profitability and is -10.45%
Evolent Health Earnings Date & Stock Price
-
What Is Evolent Health's Stock Price Today?
A single share of EVH can be purchased today for 27.24 -
What Is Evolent Health’s Stock Symbol?
Evolent Health trades on the nyse under the ticker symbol: EVH -
When Is Evolent Health’s Next Earnings Date?
The next quarterly earnings date for Evolent Health is scheduled on May 9, 2024 -
When Is EVH's next ex-dividend date?
Evolent Health's next ex-dividend date is May 7, 2024 -
How To Buy Evolent Health Stock?
You can buy Evolent Health shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Evolent Health Competitors
-
Who Are Evolent Health's Competitors?
Below is a list of companies who compete with Evolent Health or are related in some way:
Evolent Health Dividend Yield
Data Unavailable
Evolent Health Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 54.26% |
Revenue: | 45.4% | 2.5% |
Analyst Recommendations
Buy Recommendations: | 9 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 44.86 |
Upside from Last Price: | 64.67% |